Le Lézard
Classified in: Science and technology
Subject: AWD

Bedoukian Research's Robert Bedoukian, Ph.D., honored with a coveted science distinction in his name


The Research Institute for Fragrance Materials (RIFM) pays tribute to Dr. Robert Bedoukian with the Robert Bedoukian Award for Excellence in Science

MAHWAH, N.J., Sept. 13, 2024 /PRNewswire/ -- Robert Weinstein, Ph.D., the Board Chair of the Research Institute for Fragrance Materials, Inc. (RIFM), announced during RIFM's 58th Annual Meeting last night that its RIFM Board of Directors Excellence in Science Award has been officially renamed the Robert Bedoukian Excellence in Science Award to honor the life and legacy of Dr. Bedoukian.

Dr. Bedoukian, who passed away earlier this month surrounded by his loving family, led Bedoukian Research from 1986 to 2024, where he championed innovation and the science supporting the safe use of fragrance. During the Business Meeting portion of the event, Dr. Weinstein announced the Robert Bedoukian Excellence in Science Award and gave a passionate account of Dr. Bedoukian's enduring legacy.

"The Robert Bedoukian Excellence in Science Award is a fitting tribute to Dr. Bedoukian's tireless commitment to human health and environmental protection," said RIFM President Anne Marie Api, Ph.D., Fellow ATS. "We hope the Award may play a role in ensuring his devotion to stewardship and the highest scientific standards will be remembered and honored by future generations."

Dr. Bedoukian himself was a recipient of many professional and civic awards, including the 2015 Eric Bruell Distinguished Service Award, the 2021 Cecil Previdi Award for Entrepreneurial Business Achievement from the Greater Danbury Chamber of Commerce, and the Robert S. Young Humanitarian Award issued by Ability Beyond in 2018. The Association of Religious Communities honored him for community service in 2020, and in 2021, he received the Greater Danbury Good Scout Award.

About the Robert Bedoukian Excellence in Science Award

The Robert Bedoukian Excellence in Science Award is intended to provide timely recognition of original and significant contributions to fragrance science and may not be presented every year. A selection subcommittee appointed by the Board of Directors reviews all nominated candidates and recommends a finalist to the full Board of Directors for approval.

Media Contact:
The Research Institute for Fragrance Materials, Inc. (RIFM)
Gary Sullivan
Marketing & Communications Manager
[email protected]

SOURCE Research Institute for Fragrance Materials


These press releases may also interest you

at 14:24
HealthCentral Wins Top Honors at MM&M Awards for Consumer, Professional Brands
HealthCentral, a leading digital health platform serving patients living with chronic and serious illness, has taken top honors at the 2024 Medical Marketing and Media (MM+M) Awards, winning the Gold Award for Healthcare Consumer Media Brand for an...

at 14:24
REVOLT's Bet on Black Returns for Season 4 with New Host Pretty Vee, Spotlighting the Innovations of Black-Owned Beauty Brands
Today, REVOLT, the leading Black-owned and operated multimedia company, in partnership with Target and Google, is excited to announce the highly anticipated return of Bet on Black for its fourth season, premiering on October 14, 2024. This season,...

at 14:00
Comtrend Showcases OpenPON and Latest Broadband Solutions at WISPAPALOOZA 2024
Comtrend, a leader in broadband networking solutions, is set to showcase its latest innovations at WISPAPALOOZA, taking place from October 14-17 at the Paris and Horseshoe Hotels in Las Vegas, Nevada. A central focus will be on OpenPON, a...

at 13:33
FDA Approves New Treatment for Hemophilia A or B
Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without...

at 13:30
Artificial Intelligence Could be the Key to Predictive Aviation Safety
The goal for aviation is a proactive safety regime that will enable airlines, regulators, air navigation service providers, and other industry stakeholders to identify, understand, and mitigate emerging risks well before they result in an accident or...

at 13:25
U.S. FDA Approves Pfizer's HYMPAVZItm (marstacimab-hncq) for the Treatment of Adults and Adolescents with Hemophilia A or B Without Inhibitors
Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZItm (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric patients 12 years of age...

More news about Science and technology...


News published on and distributed by: